Skip to main content

Advertisement

SpringerLink
Log in

The Use of Modified Four-Dimensional Computed Tomography in Patients with Primary Hyperparathyroidism: An Argument for the Abandonment of Routine Sestamibi Single-Positron Emission Computed Tomography (SPECT)

  • Endocrine Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Four-dimensional computed tomography (4D CT) has emerged as an extremely sensitive preoperative imaging modality for primary hyperparathyroidism compared with the historical use of sestamibi and ultrasound (US). Specialized volume rendering and technical modifications further enhance this technique for operative guidance while reducing radiation exposure.

Methods

Patients undergoing parathyroidectomy for primary hyperparathyroidism from December 2010 to September 2013, carried out by two surgeons at a tertiary cancer center, were evaluated. Comparison was made between the three imaging modalities (4D CT, sestamibi, and US) for preoperative localization rate and accuracy. Biochemical parameters and radiation exposure were also analyzed.

Results

A total of 202 patients were identified from the database and 200 patients were included in the analysis. All patients underwent 4D CT (100 %), 185 sestamibi (92.5 %) and 186 US (93 %). In patients with single-gland disease (n = 153), 4D CT, sestamibi, and US were positive in 96 %, 65.4 % and 57.7 % of patients, respectively and, when positive, were accurately localized in 97.2 %, 93.4 % and 96.3 % of patients, respectively. In patients with multigland disease (MGD) [n = 47], 4D CT, sestamibi, and US predicted MGD in 32 %, 0 %, and 13.6 % of patients, respectively. With our technique modification, radiation exposure from 4D CT approached that of sestamibi.

Conclusions

Low-dose, modified 4D CT with volume rendering when compared with sestamibi has a statistically significant higher positivity rate, improved accuracy rate, provides excellent images, superior surgical planning, and has a comparable radiation exposure risk profile. Consideration should be made for the abandonment of routine sestamibi single-positron emission computed tomography (SPECT), with 4D CT as the preoperative imaging modality of choice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Eichhorn-Wharry LI, Carlin AM, Talpos GB. Mild hypercalcemia: an indication to select 4-dimensional computed tomography scan for preoperative localization of parathyroid adenomas. Am J Surg. 2011:201:334-338.

    Article  PubMed  Google Scholar 

  2. Mortenson MM, Evans DB, Lee JE, et. al. Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. J Am Coll Surg. 2008:206:888-895.

    Article  PubMed  Google Scholar 

  3. Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol. 2012:19:577-583.

    Article  PubMed  Google Scholar 

  4. Starker LF, Mahajan A, Björklund P, Sze G, Udelsman R, Carling T. 4D parathyroid CT as the initial localization study for patients with de novo primary hyperparathyroidism. Ann Surg Oncol. 2011:18:1723-1728.

    Article  PubMed  Google Scholar 

  5. Rodgers SE, Hunter GJ, Hamberg LM, et. al. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery. 2006:140:932-941.

    Article  PubMed  Google Scholar 

  6. Glynn N, Lynn N, Donagh C, et. al. The utility of 99 mTc-sestamibi scintigraphy in the localisation of parathyroid adenomas in primary hyperparathyroidism. Ir J Med Sci. 2011:180:191-194.

    Article  CAS  PubMed  Google Scholar 

  7. Witteveen JE, Kievit J, Stokkel MPM, Morreau H, Romijn JA, Hamdy NAT. Limitations of Tc99 m-MIBI-SPECT imaging scans in persistent primary hyperparathyroidism. World J Surg. 2011:35:128-139.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Gómez-Ramírez J, Sancho-Insenser JJ, Pereira JA, Jimeno J, Munné A, Sitges-Serra A. Impact of thyroid nodular disease on 99 mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism. Langenbecks Arch Surg. 2010:395:929-933.

    Article  PubMed  Google Scholar 

  9. Swanson TW, Chan SK, Jones SJ et. al. Determinants of Tc-99 m sestamibi SPECT scan sensitivity in primary hyperparathyroidism. Am J Surg. 2010:199:614-620.

    Article  PubMed  Google Scholar 

  10. Thomas DL, Bartel T, Menda Y, Howe J, Graham MM, Juweid ME. Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99 m sestamibi parathyroid scintigraphy. Clin Nucl Med. 2009:34:651-655.

    Article  PubMed  Google Scholar 

  11. Hunter GJ, Schellingerhout D, Vu TH, Perrier ND, Hamberg LM. Accuracy of four-dimensional CT for the localization of abnormal parathyroid glands in patients with primary hyperparathyroidism. Radiology. 2012:264:789-795.

    Article  PubMed  Google Scholar 

  12. Huda W, Ogden KM, Khorasani MR. Converting dose-length product to effective dose at CT. Radiology. 2008:248:995-1003.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Nuclear medicine procedure manual 2012-14 (NMPM) [paperback]. Wick Publishing, Inc.; 2012. http://www.tower.com/nuclear-medicine-procedure-manual-2012-14-wick-paperback/wapi/122153356#product_details.

  14. Lubitz CC, Stephen AE, Hodin RA, Pandharipande P. Preoperative localization strategies for primary hyperparathyroidism: an economic analysis. Ann Surg Oncol. 2012:19:4202-4209.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Vignali E, Picone A, Materazzi G, et. al. A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases. Eur J Endocrinol. 2002:146:783-788.

    Article  CAS  PubMed  Google Scholar 

  16. Chen H, Pruhs Z, Starling JR, Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005:138:583-590.

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

We would like to thank Lauren Alessi and Lizabeth Becker for their assistance with this project.

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, 14263, USA

    Moshim Kukar MD, Timothy A. Platz DO, Shicha Kumar MD & William G. Cance MD

  2. Department of Surgery, State University of New York at Buffalo, Buffalo, NY, USA

    Timothy J. Schaffner MD

  3. Department of Radiology, Roswell Park Cancer Institute, Buffalo, NY, USA

    Rania Elmarzouky MD & Ahmed Abdelhalim MD

  4. Department of Biostatistics, Roswell Park Cancer Institute, Buffalo, NY, USA

    Adrienne Groman MS

Authors
  1. Moshim Kukar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timothy A. Platz DO
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Timothy J. Schaffner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rania Elmarzouky MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Adrienne Groman MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shicha Kumar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ahmed Abdelhalim MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. William G. Cance MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Moshim Kukar MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kukar, M., Platz, T.A., Schaffner, T.J. et al. The Use of Modified Four-Dimensional Computed Tomography in Patients with Primary Hyperparathyroidism: An Argument for the Abandonment of Routine Sestamibi Single-Positron Emission Computed Tomography (SPECT). Ann Surg Oncol 22, 139–145 (2015). https://doi.org/10.1245/s10434-014-3940-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-014-3940-y

Keywords

Search

Navigation